{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:43:26Z","timestamp":1787726606212,"version":"build-2784847793"},"reference-count":162,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"DOI":"10.1007\/s12031-025-02445-1","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T14:51:34Z","timestamp":1766415094000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Is the Era of One-Size-Fits-All Alzheimer\u2019s Treatment Officially Over?"],"prefix":"10.1007","volume":"76","author":[{"given":"Swati","family":"Verma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kajal","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payal","family":"Kesharwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanika","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaya","family":"Dwivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarvesh","family":"Paliwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2639-7096","authenticated-orcid":false,"given":"Swapnil","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"key":"2445_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.clinbiochem.2019.04.015","volume":"72","author":"M Zv\u011b\u0159ov\u00e1","year":"2019","unstructured":"Zv\u011b\u0159ov\u00e1 M (2019) Clinical aspects of Alzheimer\u2019s disease. Clin Biochem 72:3\u20136","journal-title":"Clin Biochem"},{"key":"2445_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101580","author":"A Nandi","year":"2022","unstructured":"Nandi A, Counts N, Chen S, Seligman B, Tortorice D, Vigo D,\u00a0 Bloom DE (2022) Global and regional projections of the economic burden of Alzheimer's disease and related dementias from 2019 to 2050: a value of statistical life approach. EClinicalMedicine 51:101580.\u00a0https:\/\/doi.org\/10.1016\/j.eclinm.2022.101580","journal-title":"EClinicalMedicine"},{"issue":"7","key":"2445_CR3","first-page":"1170","volume":"10","author":"L Anwal","year":"2021","unstructured":"Anwal L (2021) A comprehensive review on Alzheimer\u2019s disease. World J Pharm Pharm Sci 10(7):1170","journal-title":"World J Pharm Pharm Sci"},{"key":"2445_CR4","doi-asserted-by":"crossref","unstructured":"Shukla AK, Nilgirwar PS, Bali SD (2025) Current Pharmacological treatments for neurodegenerative diseases, in The neurodegeneration revolution. Elsevier, pp 117\u2013126","DOI":"10.1016\/B978-0-443-28822-7.00005-2"},{"issue":"1","key":"2445_CR5","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41392-024-01911-3","volume":"9","author":"J Zhang","year":"2024","unstructured":"Zhang J et al (2024) Recent advances in alzheimer\u2019s disease: Mechanisms, clinical trials and new drug development strategies. Signal Transduct Target Therapy 9(1):211","journal-title":"Signal Transduct Target Therapy"},{"key":"2445_CR6","unstructured":"Shankar S et al (2025) Bridging Brains and Machines: A Unified Frontier in Neuroscience, Artificial Intelligence, and Neuromorphic Systems. arXiv preprint arXiv:2507.10722"},{"key":"2445_CR7","doi-asserted-by":"publisher","first-page":"742408","DOI":"10.3389\/fnagi.2022.742408","volume":"14","author":"MB Abubakar","year":"2022","unstructured":"Abubakar MB et al (2022) Alzheimer\u2019s disease: an update and insights into pathophysiology. Front Aging Neurosci 14:742408","journal-title":"Front Aging Neurosci"},{"issue":"7","key":"2445_CR8","doi-asserted-by":"publisher","first-page":"4833","DOI":"10.1007\/s12035-015-9390-0","volume":"53","author":"P Talwar","year":"2016","unstructured":"Talwar P et al (2016) Dissecting complex and multifactorial nature of Alzheimer\u2019s disease pathogenesis: a clinical, genomic, and systems biology perspective. Mol Neurobiol 53(7):4833\u20134864","journal-title":"Mol Neurobiol"},{"issue":"1","key":"2445_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00702-021-02449-2","volume":"129","author":"KA Jellinger","year":"2022","unstructured":"Jellinger KA (2022) Recent update on the heterogeneity of the Alzheimer\u2019s disease spectrum. J Neural Transm 129(1):1\u201324","journal-title":"J Neural Transm"},{"issue":"11","key":"2445_CR10","doi-asserted-by":"publisher","first-page":"450","DOI":"10.3390\/metabo10110450","volume":"10","author":"JW B\u0142aszczyk","year":"2020","unstructured":"B\u0142aszczyk JW (2020) Energy metabolism decline in the aging brain\u2014pathogenesis of neurodegenerative disorders. Metabolites 10(11):450","journal-title":"Metabolites"},{"issue":"9","key":"2445_CR11","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1002\/1873-3468.14298","volume":"596","author":"D Trigo","year":"2022","unstructured":"Trigo D et al (2022) Mitochondria, energy, and metabolism in neuronal health and disease. FEBS Lett 596(9):1095\u20131110","journal-title":"FEBS Lett"},{"key":"2445_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.00213","volume":"14","author":"VR Muddapu","year":"2020","unstructured":"Muddapu VR et al (2020) Neurodegenerative diseases\u2013is metabolic deficiency the root cause? Front Neurosci 14:213","journal-title":"Front Neurosci"},{"issue":"11","key":"2445_CR13","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/s41574-021-00551-9","volume":"17","author":"M Kitada","year":"2021","unstructured":"Kitada M, Koya D (2021) Autophagy in metabolic disease and ageing. Nat Rev Endocrinol 17(11):647\u2013661","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"2445_CR14","doi-asserted-by":"publisher","first-page":"547","DOI":"10.3390\/medicina61030547","volume":"61","author":"F Palacino","year":"2025","unstructured":"Palacino F, Manganotti P, Benussi A (2025) Targeting neural oscillations for cognitive enhancement in Alzheimer\u2019s disease. Medicina (Kaunas) 61(3):547","journal-title":"Medicina (Kaunas)"},{"issue":"2","key":"2445_CR15","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3390\/biomedicines11020355","volume":"11","author":"S Ribari\u010d","year":"2023","unstructured":"Ribari\u010d S (2023) Detecting early cognitive decline in Alzheimer\u2019s disease with brain synaptic structural and functional evaluation. Biomedicines 11(2):355","journal-title":"Biomedicines"},{"issue":"1","key":"2445_CR16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3390\/bioengineering11010045","volume":"11","author":"KL Nystuen","year":"2024","unstructured":"Nystuen KL et al (2024) Alzheimer\u2019s disease: models and molecular mechanisms informing disease and treatments. Bioengineering (Basel) 11(1):45","journal-title":"Bioengineering (Basel)"},{"issue":"10","key":"2445_CR17","doi-asserted-by":"publisher","first-page":"850","DOI":"10.2174\/0115680266282492240220101049","volume":"24","author":"P Madar","year":"2024","unstructured":"Madar P et al (2024) The unveiling of therapeutic targets for alzheimer\u2019s disease: an integrative review. Curr Top Med Chem 24(10):850\u2013868","journal-title":"Curr Top Med Chem"},{"key":"2445_CR18","unstructured":"Pais MV, Forlenza OV New Perspectives for Treatment in Alzheimer\u2019s Disease. Pharmacological Treatment of Alzheimer\u2019s Disease: p. 199"},{"issue":"12","key":"2445_CR19","doi-asserted-by":"publisher","first-page":"5227","DOI":"10.1038\/s44319-024-00294-4","volume":"25","author":"P Hunter","year":"2024","unstructured":"Hunter P (2024) The controversy around anti-amyloid antibodies for treating Alzheimer\u2019s disease: the European medical agency\u2019s ruling against the latest anti-amyloid drugs highlights the ongoing debate about their safety and efficacy. EMBO Rep 25(12):5227\u20135231","journal-title":"EMBO Rep"},{"issue":"1","key":"2445_CR20","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13024-017-0192-x","volume":"12","author":"CE Leyns","year":"2017","unstructured":"Leyns CE, Holtzman DM (2017) Glial contributions to neurodegeneration in tauopathies. Mol Neurodegeneration 12(1):50","journal-title":"Mol Neurodegeneration"},{"issue":"10","key":"2445_CR21","doi-asserted-by":"publisher","first-page":"978","DOI":"10.2174\/1389450123666220526155144","volume":"23","author":"A Malaiya","year":"2022","unstructured":"Malaiya A et al (2022) Recent update on the alzheimer\u2019s disease progression, diagnosis and treatment approaches. Curr Drug Targets 23(10):978\u20131001","journal-title":"Curr Drug Targets"},{"issue":"1","key":"2445_CR22","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1152\/physrev.00030.2022","volume":"104","author":"M Perluigi","year":"2024","unstructured":"Perluigi M, Di Domenico F, Butterfield DA (2024) Oxidative damage in neurodegeneration: roles in the pathogenesis and progression of alzheimer disease. Physiol Rev 104(1):103\u2013197","journal-title":"Physiol Rev"},{"key":"2445_CR23","doi-asserted-by":"publisher","unstructured":"Gallardo G,\u00a0 Holtzman DM (2019) Amyloid-\u03b2 and tau at the crossroads of Alzheimer's disease. advances in experimental medicine and biology 1184:187\u2013203. https:\/\/doi.org\/10.1007\/978-981-32-9358-8_16","DOI":"10.1007\/978-981-32-9358-8_16"},{"key":"2445_CR24","first-page":"17","volume":"3","author":"I Ferrer","year":"2022","unstructured":"Ferrer I (2022) Alzheimer\u2019s disease is an inherent, natural part of human brain aging: an integrated perspective. Free Neuropathology 3:17","journal-title":"Free Neuropathology"},{"issue":"1","key":"2445_CR25","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3934\/Neuroscience.2021005","volume":"8","author":"M Calabr\u00f2","year":"2020","unstructured":"Calabr\u00f2 M et al (2020) The biological pathways of alzheimer disease: A review. AIMS Neurosci 8(1):86","journal-title":"AIMS Neurosci"},{"issue":"14","key":"2445_CR26","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1016\/j.neuron.2023.04.018","volume":"111","author":"J Rollo","year":"2023","unstructured":"Rollo J, Crawford J, Hardy J (2023) A dynamical systems approach for multiscale synthesis of Alzheimer\u2019s pathogenesis. Neuron 111(14):2126\u20132139","journal-title":"Neuron"},{"issue":"s1","key":"2445_CR27","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.3233\/JAD-179932","volume":"64","author":"H Hampel","year":"2018","unstructured":"Hampel H et al (2018) Revolution of alzheimer precision neurology. Passageway of systems biology and neurophysiology. J Alzheimer\u2019s Disease 64(s1):S47\u2013S105","journal-title":"J Alzheimer\u2019s Disease"},{"issue":"1","key":"2445_CR28","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","volume":"14","author":"MA DeTure","year":"2019","unstructured":"DeTure MA, Dickson DW (2019) The neuropathological diagnosis of alzheimer\u2019s disease. Mol Neurodegeneration 14(1):32","journal-title":"Mol Neurodegeneration"},{"issue":"3","key":"2445_CR29","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3390\/jpm10030061","volume":"10","author":"C Villa","year":"2020","unstructured":"Villa C et al (2020) Molecular and imaging biomarkers in alzheimer\u2019s disease: a focus on recent insights. J Personalized Med 10(3):61","journal-title":"J Personalized Med"},{"issue":"10","key":"2445_CR30","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.3390\/biom10101439","volume":"10","author":"JR Perea","year":"2020","unstructured":"Perea JR, Bol\u00f3s M, Avila J (2020) Microglia in Alzheimer\u2019s disease in the context of Tau pathology. Biomolecules 10(10):1439","journal-title":"Biomolecules"},{"issue":"3","key":"2445_CR31","doi-asserted-by":"publisher","first-page":"540","DOI":"10.3390\/cells10030540","volume":"10","author":"P Preman","year":"2021","unstructured":"Preman P et al (2021) Astrocytes in Alzheimer\u2019s disease: pathological significance and molecular pathways. Cells 10(3):540","journal-title":"Cells"},{"key":"2445_CR32","doi-asserted-by":"crossref","unstructured":"Combs B et al (2020) Tau and axonal transport misregulation in tauopathies. Tau Biology 81\u201395","DOI":"10.1007\/978-981-32-9358-8_7"},{"issue":"21","key":"2445_CR33","doi-asserted-by":"publisher","first-page":"12841","DOI":"10.3390\/ijms232112841","volume":"23","author":"P Rawat","year":"2022","unstructured":"Rawat P et al (2022) Phosphorylated Tau in alzheimer\u2019s disease and other Tauopathies. Int J Mol Sci 23(21):12841","journal-title":"Int J Mol Sci"},{"key":"2445_CR34","unstructured":"Fernandes AIP (2015) Role of Endoplasmic Reticulum Stress in Alzheimer\u2019s Disease-Associated Neuronal and Endothelial Dysfunction. Universidade de Coimbra (Portugal)"},{"key":"2445_CR35","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3389\/fnmol.2017.00191","volume":"10","author":"C Arcuri","year":"2017","unstructured":"Arcuri C et al (2017) The pathophysiological role of microglia in dynamic surveillance, phagocytosis and structural remodeling of the developing CNS. Front Mol Neurosci 10:191","journal-title":"Front Mol Neurosci"},{"issue":"7","key":"2445_CR36","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.3390\/cells9071717","volume":"9","author":"JA Rodr\u00edguez-G\u00f3mez","year":"2020","unstructured":"Rodr\u00edguez-G\u00f3mez JA et al (2020) Microglia: agents of the CNS pro-inflammatory response. Cells 9(7):1717","journal-title":"Cells"},{"issue":"9","key":"2445_CR37","doi-asserted-by":"publisher","first-page":"8434","DOI":"10.3390\/ijms24098434","volume":"24","author":"SL Valles","year":"2023","unstructured":"Valles SL et al (2023) Functions of astrocytes under normal conditions and after a brain disease. Int J Mol Sci 24(9):8434","journal-title":"Int J Mol Sci"},{"key":"2445_CR38","doi-asserted-by":"publisher","first-page":"591690","DOI":"10.3389\/fneur.2020.591690","volume":"11","author":"QP Verhoog","year":"2020","unstructured":"Verhoog QP et al (2020) Astrocytes as guardians of neuronal excitability: mechanisms underlying epileptogenesis. Front Neurol 11:591690","journal-title":"Front Neurol"},{"issue":"1","key":"2445_CR39","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3390\/neuroglia6010004","volume":"6","author":"OK Ijomone","year":"2025","unstructured":"Ijomone OK et al (2025) Glial perturbation in metal neurotoxicity: implications for brain disorders. Neuroglia 6(1):4","journal-title":"Neuroglia"},{"issue":"Suppl 1","key":"2445_CR40","doi-asserted-by":"publisher","first-page":"L42","DOI":"10.1186\/2193-1801-4-S1-L42","volume":"4","author":"H Vieira","year":"2015","unstructured":"Vieira H et al (2015) Carbon monoxide targeting mitochondria in astrocytes: modulation of cell metabolism, redox response and cell death. SpringerPlus 4(Suppl 1):L42","journal-title":"SpringerPlus"},{"key":"2445_CR41","doi-asserted-by":"crossref","unstructured":"Soto-Rojas LO et al (2021) The neurovascular unit dysfunction in Alzheimer\u2019s disease. International Journal of Molecular Sci 22(4):2022","DOI":"10.3390\/ijms22042022"},{"issue":"4","key":"2445_CR42","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.3390\/ijms21041539","volume":"21","author":"C De Luca","year":"2020","unstructured":"De Luca C et al (2020) Neurons, glia, extracellular matrix and neurovascular unit: a systems biology approach to the complexity of synaptic plasticity in health and disease. Int J Mol Sci 21(4):1539","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2445_CR43","first-page":"181","volume":"7","author":"N Bari\u0107","year":"2020","unstructured":"Bari\u0107 N (2020) Perivascular drainage of amyloid beta (A\u03b2) and waste products from the brain and its failure. Glycative Stress Res 7(2):181\u2013195","journal-title":"Glycative Stress Res"},{"issue":"1","key":"2445_CR44","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/cns.13569","volume":"27","author":"X Huang","year":"2021","unstructured":"Huang X, Hussain B, Chang J (2021) Peripheral inflammation and blood\u2013brain barrier disruption: effects and mechanisms. CNS Neurosci Ther 27(1):36\u201347","journal-title":"CNS Neurosci Ther"},{"issue":"3","key":"2445_CR45","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3390\/life11030262","volume":"11","author":"I Pomytkin","year":"2021","unstructured":"Pomytkin I, Pinelis V (2021) Brain insulin resistance: focus on insulin receptor-mitochondria interactions. Life 11(3):262","journal-title":"Life"},{"issue":"1","key":"2445_CR46","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1038\/s42003-021-02825-4","volume":"4","author":"S Garbarino","year":"2021","unstructured":"Garbarino S et al (2021) Role of sleep deprivation in immune-related disease risk and outcomes. Commun Biology 4(1):1304","journal-title":"Commun Biology"},{"key":"2445_CR47","unstructured":"Arvidsson L (2013) Features of adult neural progenitor cells. Karolinska Institutet (Sweden)"},{"issue":"1","key":"2445_CR48","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13030-023-00268-3","volume":"17","author":"G Fricchione","year":"2023","unstructured":"Fricchione G (2023) Mind body medicine: a modern bio-psycho-social model forty-five years after Engel. Biopsychosoc Med 17(1):12","journal-title":"Biopsychosoc Med"},{"issue":"9","key":"2445_CR49","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1111\/cns.13899","volume":"28","author":"F Yu","year":"2022","unstructured":"Yu F et al (2022) Phagocytic microglia and macrophages in brain injury and repair. CNS Neurosci Ther 28(9):1279\u20131293","journal-title":"CNS Neurosci Ther"},{"issue":"2","key":"2445_CR50","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1002\/jnr.24419","volume":"98","author":"E Gaband\u00e9-Rodr\u00edguez","year":"2020","unstructured":"Gaband\u00e9-Rodr\u00edguez E, Keane L, Capasso M (2020) Microglial phagocytosis in aging and Alzheimer\u2019s disease. J Neurosci Res 98(2):284\u2013298","journal-title":"J Neurosci Res"},{"issue":"3","key":"2445_CR51","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1152\/physrev.00015.2020","volume":"101","author":"C Ferrari","year":"2021","unstructured":"Ferrari C, Sorbi S (2021) The complexity of Alzheimer\u2019s disease: an evolving puzzle. Physiol Rev 101(3):1047\u20131081","journal-title":"Physiol Rev"},{"issue":"1","key":"2445_CR52","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41583-021-00533-w","volume":"23","author":"GB Frisoni","year":"2022","unstructured":"Frisoni GB et al (2022) The probabilistic model of Alzheimer disease: the amyloid hypothesis revised. Nat Rev Neurosci 23(1):53\u201366","journal-title":"Nat Rev Neurosci"},{"issue":"21","key":"2445_CR53","doi-asserted-by":"publisher","first-page":"12924","DOI":"10.3390\/ijms232112924","volume":"23","author":"U Sehar","year":"2022","unstructured":"Sehar U et al (2022) Amyloid beta in aging and alzheimer\u2019s disease. Int J Mol Sci 23(21):12924","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2445_CR54","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13041-024-01118-1","volume":"17","author":"A Azargoonjahromi","year":"2024","unstructured":"Azargoonjahromi A (2024) The duality of amyloid-\u03b2: its role in normal and Alzheimer\u2019s disease states. Mol Brain 17(1):44","journal-title":"Mol Brain"},{"issue":"5","key":"2445_CR55","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1134\/S002689332104004X","volume":"55","author":"D Garbuz","year":"2021","unstructured":"Garbuz D, Zatsepina O, Evgen\u2019ev M (2021) Beta amyloid, Tau protein, and neuroinflammation: an attempt to integrate different hypotheses of Alzheimer\u2019s disease pathogenesis. Mol Biol 55(5):670\u2013682","journal-title":"Mol Biol"},{"issue":"3","key":"2445_CR56","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S1474-4422(13)70276-X","volume":"13","author":"R Yan","year":"2014","unstructured":"Yan R, Vassar R (2014) Targeting the \u03b2 secretase BACE1 for Alzheimer\u2019s disease therapy. Lancet Neurol 13(3):319\u2013329","journal-title":"Lancet Neurol"},{"issue":"2","key":"2445_CR57","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1083\/jcb.201806205","volume":"218","author":"L Liu","year":"2019","unstructured":"Liu L et al (2019) A cellular complex of BACE1 and \u03b3-secretase sequentially generates A\u03b2 from its full-length precursor. J Cell Biol 218(2):644\u2013663","journal-title":"J Cell Biol"},{"issue":"4","key":"2445_CR58","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/s12276-022-00754-8","volume":"54","author":"J-Y Hur","year":"2022","unstructured":"Hur J-Y (2022) \u03b3-Secretase in Alzheimer\u2019s disease. Exp Mol Med 54(4):433\u2013446","journal-title":"Exp Mol Med"},{"issue":"355","key":"2445_CR59","doi-asserted-by":"publisher","first-page":"ra116","DOI":"10.1126\/scisignal.2005770","volume":"7","author":"JW Haskins","year":"2014","unstructured":"Haskins JW, Nguyen DX, Stern DF (2014) Neuregulin 1\u2013activated ERBB4 interacts with YAP to induce Hippo pathway target genes and promote cell migration. Sci Signal 7(355):ra116\u2013ra116","journal-title":"Sci Signal"},{"issue":"1","key":"2445_CR60","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3390\/ph12010041","volume":"12","author":"MA Maia","year":"2019","unstructured":"Maia MA, Sousa E (2019) BACE-1 and \u03b3-secretase as therapeutic targets for Alzheimer\u2019s disease. Pharmaceuticals 12(1):41","journal-title":"Pharmaceuticals"},{"issue":"5","key":"2445_CR61","first-page":"S411","volume":"10","author":"DK Lahiri","year":"2014","unstructured":"Lahiri DK et al (2014) Lessons from a BACE1 inhibitor trial: off-site but not off base. Alzheimer\u2019s Dement 10(5):S411\u2013S419","journal-title":"Alzheimer\u2019s Dement"},{"issue":"20","key":"2445_CR62","first-page":"3589","volume":"15","author":"MR Islam","year":"2024","unstructured":"Islam MR et al (2024) Mechanistic approach to immunity and immunotherapy of Alzheimer\u2019s disease: a review. ACS Chem Neurosci 15(20):3589\u20133614","journal-title":"ACS Chem Neurosci"},{"issue":"12","key":"2445_CR63","doi-asserted-by":"publisher","first-page":"6683","DOI":"10.3390\/ijms25126683","volume":"25","author":"SK Niazi","year":"2024","unstructured":"Niazi SK, Mariam Z, Magoola M (2024) Engineered antibodies to improve efficacy against neurodegenerative disorders. Int J Mol Sci 25(12):6683","journal-title":"Int J Mol Sci"},{"issue":"4","key":"2445_CR64","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41582-024-01053-8","volume":"21","author":"SM Greenberg","year":"2025","unstructured":"Greenberg SM, Bax F, van Veluw SJ (2025) Amyloid-related imaging abnormalities: manifestations, metrics and mechanisms. Nat Reviews Neurol 21(4):193\u2013203","journal-title":"Nat Reviews Neurol"},{"key":"2445_CR65","doi-asserted-by":"publisher","first-page":"103949","DOI":"10.1016\/j.mcn.2024.103949","volume":"130","author":"M Johannesson","year":"2024","unstructured":"Johannesson M et al (2024) Lecanemab demonstrates highly selective binding to A\u03b2 protofibrils isolated from alzheimer\u2019s disease brains. Mol Cell Neurosci 130:103949","journal-title":"Mol Cell Neurosci"},{"issue":"7","key":"2445_CR66","doi-asserted-by":"publisher","first-page":"e395","DOI":"10.1016\/S2666-7568(21)00144-6","volume":"2","author":"DO Alawode","year":"2021","unstructured":"Alawode DO et al (2021) Donanemab removes Alzheimer\u2019s plaques: what is special about its target? Lancet Healthy Longev 2(7):e395\u2013e396","journal-title":"Lancet Healthy Longev"},{"key":"2445_CR67","doi-asserted-by":"crossref","unstructured":"Campbell B et al (2024) Binding Characteristics of PRX012 Surrogate Demonstrate Potent Engagement of Toxic Amyloid Beta Protofibrils and Robust Clearance of Pyroglutamate-modified Amyloid Beta (P7-9.003). in Neurology. Lippincott Williams & Wilkins Hagerstown, MD","DOI":"10.1212\/WNL.0000000000205068"},{"issue":"1","key":"2445_CR68","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s41983-025-00968-3","volume":"61","author":"Tb Ameen","year":"2025","unstructured":"Ameen Tb et al (2025) Amyloid solutions: lecanemab, gantenerumab, and Donanemab in the treatment of alzheimer\u2019s disease. Egypt J Neurol Psychiatry Neurosurg 61(1):37","journal-title":"Egypt J Neurol Psychiatry Neurosurg"},{"issue":"1","key":"2445_CR69","first-page":"8501693","volume":"2016","author":"J Folch","year":"2016","unstructured":"Folch J et al (2016) Current research therapeutic strategies for alzheimer\u2019s disease treatment. Neural Plast 2016(1):8501693","journal-title":"Neural Plast"},{"issue":"1","key":"2445_CR70","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s40035-021-00270-1","volume":"10","author":"M Wu","year":"2021","unstructured":"Wu M et al (2021) The role of pathological Tau in synaptic dysfunction in Alzheimer\u2019s diseases. Transl Neurodegener 10(1):45","journal-title":"Transl Neurodegener"},{"key":"2445_CR71","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3389\/fnagi.2018.00027","volume":"10","author":"Y Zhou","year":"2018","unstructured":"Zhou Y et al (2018) Relevance of phosphorylation and truncation of Tau to the etiopathogenesis of Alzheimer\u2019s disease. Front Aging Neurosci 10:27","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"2445_CR72","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/biom6020021","volume":"6","author":"M Medina","year":"2016","unstructured":"Medina M, Hern\u00e1ndez F, Avila J (2016) New features about Tau function and dysfunction. Biomolecules 6(2):21","journal-title":"Biomolecules"},{"issue":"1","key":"2445_CR73","volume":"2015","author":"SM Alavi Naini","year":"2015","unstructured":"Alavi Naini SM, Soussi-Yanicostas N (2015) Tau hyperphosphorylation and oxidative stress, a critical vicious circle in neurodegenerative tauopathies? Oxid Med Cell Longev 2015(1):151979","journal-title":"Oxid Med Cell Longev"},{"key":"2445_CR74","doi-asserted-by":"crossref","unstructured":"Luna-Mu\u00f1oz J et al (2013) Phosphorylation of tau protein associated as a protective mechanism in the presence of toxic, C-terminally truncated tau in Alzheimer\u2019s disease, in Understanding alzheimer\u2019s disease. IntechOpen","DOI":"10.5772\/54228"},{"issue":"1","key":"2445_CR75","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nrn.2015.1","volume":"17","author":"Y Wang","year":"2016","unstructured":"Wang Y, Mandelkow E (2016) Tau in physiology and pathology. Nat Rev Neurosci 17(1):22\u201335","journal-title":"Nat Rev Neurosci"},{"key":"2445_CR76","doi-asserted-by":"publisher","first-page":"977411","DOI":"10.3389\/fnagi.2022.977411","volume":"14","author":"I Mumtaz","year":"2022","unstructured":"Mumtaz I et al (2022) Clinical relevance of biomarkers, new therapeutic approaches, and role of post-translational modifications in the pathogenesis of Alzheimer\u2019s disease. Front Aging Neurosci 14:977411","journal-title":"Front Aging Neurosci"},{"key":"2445_CR77","unstructured":"Tzeplaeff L (2021) Memory dysfunctions and associated epigenetic and transcriptomic changes in an ALS\/FTD mouse model linked to a FUS mutation. Universit\u00e9 de Strasbourg"},{"issue":"6","key":"2445_CR78","doi-asserted-by":"publisher","first-page":"fcac286","DOI":"10.1093\/braincomms\/fcac286","volume":"4","author":"Y Hirota","year":"2022","unstructured":"Hirota Y et al (2022) Distinct brain pathologies associated with alzheimer\u2019s disease biomarker-related phospho-tau 181 and phospho-tau 217 in app knock-in mouse models of amyloid-\u03b2 amyloidosis. Brain Commun 4(6):fcac286","journal-title":"Brain Commun"},{"issue":"7","key":"2445_CR79","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.3390\/biomedicines10071550","volume":"10","author":"M Italia","year":"2022","unstructured":"Italia M et al (2022) NMDA and AMPA receptors at synapses: novel targets for Tau and \u03b1-synuclein proteinopathies. Biomedicines 10(7):1550","journal-title":"Biomedicines"},{"key":"2445_CR80","unstructured":"Musardo S (2016) Molecular aspects of alzheimer\u2019s disease pathogenesis: from local spine trafficking to long distance spine to nucleus signalling.\u2018 Towards new therapeutics intervention"},{"issue":"1","key":"2445_CR81","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41573-023-00823-1","volume":"23","author":"B Dejanovic","year":"2024","unstructured":"Dejanovic B, Sheng M, Hanson JE (2024) Targeting synapse function and loss for treatment of neurodegenerative diseases. Nat Rev Drug Discov 23(1):23\u201342","journal-title":"Nat Rev Drug Discov"},{"issue":"13","key":"2445_CR82","doi-asserted-by":"publisher","first-page":"6450","DOI":"10.3390\/ijms26136450","volume":"26","author":"A Vialko","year":"2025","unstructured":"Vialko A, Cha\u0142upnik P, Szyma\u0144ska E (2025) Positive AMPA and Kainate receptor modulators and their therapeutic potential in CNS diseases: A comprehensive review. Int J Mol Sci 26(13):6450","journal-title":"Int J Mol Sci"},{"key":"2445_CR83","doi-asserted-by":"crossref","unstructured":"Garro-Mart\u00ednez E, Adell A (2021) AMPA receptor potentiators as potential Rapid-Acting antidepressants, in New Rapid-acting antidepressants. Springer, pp 85\u2013109","DOI":"10.1007\/978-3-030-79790-4_6"},{"key":"2445_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e12292","author":"M Nayak","year":"2022","unstructured":"Nayak M, Das D, Pradhan J, Ahmed RG, Laureano-Melo R, Dandapat J (2022) Epigenetic signature in neural plasticity: the journey so far and journey ahead. Heliyon 8(12):e12292.\u00a0https:\/\/doi.org\/10.1016\/j.heliyon.2022.e12292","journal-title":"Heliyon"},{"issue":"1","key":"2445_CR85","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.neuron.2019.01.016","volume":"102","author":"EJ Nestler","year":"2019","unstructured":"Nestler EJ, L\u00fcscher C (2019) The molecular basis of drug addiction: linking epigenetic to synaptic and circuit mechanisms. Neuron 102(1):48\u201359","journal-title":"Neuron"},{"key":"2445_CR86","doi-asserted-by":"publisher","first-page":"586731","DOI":"10.3389\/fnmol.2020.586731","volume":"13","author":"S Jiang","year":"2020","unstructured":"Jiang S, Bhaskar K (2020) Degradation and transmission of Tau by autophagic-endolysosomal networks and potential therapeutic targets for Tauopathy. Front Mol Neurosci 13:586731","journal-title":"Front Mol Neurosci"},{"issue":"7","key":"2445_CR87","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1096\/fj.201700359","volume":"31","author":"RA Nixon","year":"2017","unstructured":"Nixon RA (2017) Amyloid precursor protein and endosomal\u2013lysosomal dysfunction in Alzheimer\u2019s disease: inseparable partners in a multifactorial disease. FASEB J 31(7):2729","journal-title":"FASEB J"},{"issue":"11","key":"2445_CR88","first-page":"739","volume":"42","author":"W Jeong","year":"2019","unstructured":"Jeong W et al (2019) ApoE4-induced cholesterol dysregulation and its brain cell type-specific implications in the pathogenesis of alzheimer\u2019s disease. Mol Cells 42(11):739\u2013746","journal-title":"Mol Cells"},{"issue":"4","key":"2445_CR89","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/j.1365-2982.2009.01445.x","volume":"22","author":"T Wedel","year":"2010","unstructured":"Wedel T et al (2010) Diverticular disease is associated with an enteric neuropathy as revealed by morphometric analysis. Neurogastroenterology Motil 22(4):407\u2013e94","journal-title":"Neurogastroenterology Motil"},{"issue":"9","key":"2445_CR90","doi-asserted-by":"publisher","first-page":"6524","DOI":"10.1002\/jcp.26583","volume":"233","author":"K Hosseinpour-Moghaddam","year":"2018","unstructured":"Hosseinpour-Moghaddam K, Caraglia M, Sahebkar A (2018) Autophagy induction by trehalose: molecular mechanisms and therapeutic impacts. J Cell Physiol 233(9):6524\u20136543","journal-title":"J Cell Physiol"},{"issue":"19","key":"2445_CR91","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.3390\/cells11193153","volume":"11","author":"B Franco-Ju\u00e1rez","year":"2022","unstructured":"Franco-Ju\u00e1rez B et al (2022) TFEB; beyond its role as an autophagy and lysosomes regulator. Cells 11(19):3153","journal-title":"Cells"},{"issue":"16","key":"2445_CR92","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.3390\/cells11162562","volume":"11","author":"V Hubert","year":"2022","unstructured":"Hubert V et al (2022) Modulating chaperone-mediated autophagy and its clinical applications in cancer. Cells 11(16):2562","journal-title":"Cells"},{"key":"2445_CR93","doi-asserted-by":"crossref","unstructured":"Yang Q, Wang R, Zhu L (2019) Chaperone-mediated autophagy. Autophagy: Biology and Diseases: Basic Science 435\u2013452","DOI":"10.1007\/978-981-15-0602-4_20"},{"issue":"771","key":"2445_CR94","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abo1997","volume":"16","author":"B Zhu","year":"2024","unstructured":"Zhu B et al (2024) Single-cell transcriptomic and proteomic analysis of Parkinson\u2019s disease brains. Sci Transl Med 16(771):eabo1997","journal-title":"Sci Transl Med"},{"issue":"7761","key":"2445_CR95","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41586-019-1195-2","volume":"570","author":"H Mathys","year":"2019","unstructured":"Mathys H et al (2019) Single-cell transcriptomic analysis of Alzheimer\u2019s disease. Nature 570(7761):332\u2013337","journal-title":"Nature"},{"key":"2445_CR96","doi-asserted-by":"publisher","first-page":"1610717","DOI":"10.3389\/fimmu.2025.1610717","volume":"16","author":"M-M Li","year":"2025","unstructured":"Li M-M et al (2025) Programmed cell death signatures (PCDS)-Driven microglial transformation in alzheimer\u2019s disease: Single-Cell transcriptomics and functional validation. Front Immunol 16:1610717","journal-title":"Front Immunol"},{"issue":"1","key":"2445_CR97","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1186\/s40001-023-01360-8","volume":"28","author":"Q Wang","year":"2023","unstructured":"Wang Q et al (2023) SNAP25 is a potential target for early stage Alzheimer\u2019s disease and Parkinson\u2019s disease. Eur J Med Res 28(1):570","journal-title":"Eur J Med Res"},{"key":"2445_CR98","doi-asserted-by":"publisher","first-page":"884748","DOI":"10.3389\/fcell.2022.884748","volume":"10","author":"R Cuevas-Diaz Duran","year":"2022","unstructured":"Cuevas-Diaz Duran R et al (2022) Single-cell and single-nuclei RNA sequencing as powerful tools to Decipher cellular heterogeneity and dysregulation in neurodegenerative diseases. Front Cell Dev Biology 10:884748","journal-title":"Front Cell Dev Biology"},{"key":"2445_CR99","volume-title":"Using chimeric models to study the interactions between human microglia and alzheimer\u2019s disease pathology in vivo","author":"MA Coburn","year":"2021","unstructured":"Coburn MA (2021) Using chimeric models to study the interactions between human microglia and alzheimer\u2019s disease pathology in vivo. University of California, Irvine"},{"issue":"1","key":"2445_CR100","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40478-023-01526-9","volume":"11","author":"JM Lawrence","year":"2023","unstructured":"Lawrence JM et al (2023) Roles of neuropathology-associated reactive astrocytes: a systematic review. Acta Neuropathol Commun 11(1):42","journal-title":"Acta Neuropathol Commun"},{"key":"2445_CR101","doi-asserted-by":"publisher","first-page":"689952","DOI":"10.3389\/fnmol.2021.689952","volume":"14","author":"C Giorgi","year":"2021","unstructured":"Giorgi C, Marinelli S (2021) Roles and transcriptional responses of inhibitory neurons in learning and memory. Front Mol Neurosci 14:689952","journal-title":"Front Mol Neurosci"},{"key":"2445_CR102","unstructured":"McLachlan CA (2024) Functional and molecular properties of Learning-Related neuroplasticity in perirhinal cortex. Boston University"},{"key":"2445_CR103","unstructured":"Gaunt J (2018) A viral approach to translatome profiling of CA1 neurons during associative recognition memory formation. University of Bristol"},{"issue":"1","key":"2445_CR104","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1038\/s41598-021-82098-3","volume":"11","author":"S El-Sappagh","year":"2021","unstructured":"El-Sappagh S et al (2021) A multilayer multimodal detection and prediction model based on explainable artificial intelligence for Alzheimer\u2019s disease. Sci Rep 11(1):2660","journal-title":"Sci Rep"},{"issue":"9","key":"2445_CR105","first-page":"1797","volume":"28","author":"M Mil\u00e0-Alom\u00e0","year":"2022","unstructured":"Mil\u00e0-Alom\u00e0 M et al (2022) Plasma p-tau231 and p-tau217 as state markers of amyloid-\u03b2 pathology in preclinical Alzheimer\u2019s disease. Nat Med 28(9):1797\u20131801","journal-title":"Nat Med"},{"issue":"S1","key":"2445_CR106","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3138\/jmvfh.2019-0036","volume":"6","author":"SG Rhind","year":"2020","unstructured":"Rhind SG et al (2020) Biomarkers for military mental health: Insights, challenges, and future prospects. J Military Veteran Family Health 6(S1):51\u201367","journal-title":"J Military Veteran Family Health"},{"issue":"2","key":"2445_CR107","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s11306-019-1473-x","volume":"15","author":"M Zhang","year":"2019","unstructured":"Zhang M et al (2019) UHPLC-QTOF\/MS-based metabolomics investigation for the protective mechanism of Danshen in Alzheimer\u2019s disease cell model induced by A\u03b21\u201342. Metabolomics 15(2):13","journal-title":"Metabolomics"},{"issue":"1","key":"2445_CR108","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41467-019-13668-3","volume":"11","author":"I Mart\u00ednez-Reyes","year":"2020","unstructured":"Mart\u00ednez-Reyes I, Chandel NS (2020) Mitochondrial TCA cycle metabolites control physiology and disease. Nat Commun 11(1):102","journal-title":"Nat Commun"},{"issue":"1","key":"2445_CR109","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12974-021-02250-8","volume":"18","author":"Y Zhao","year":"2021","unstructured":"Zhao Y et al (2021) NAD\u2009+\u2009improves cognitive function and reduces neuroinflammation by ameliorating mitochondrial damage and decreasing ROS production in chronic cerebral hypoperfusion models through Sirt1\/PGC-1\u03b1 pathway. J Neuroinflamm 18(1):207","journal-title":"J Neuroinflamm"},{"issue":"7","key":"2445_CR110","doi-asserted-by":"publisher","first-page":"998","DOI":"10.3390\/biom12070998","volume":"12","author":"K Hestad","year":"2022","unstructured":"Hestad K et al (2022) The role of tryptophan dysmetabolism and quinolinic acid in depressive and neurodegenerative diseases. Biomolecules 12(7):998","journal-title":"Biomolecules"},{"key":"2445_CR111","doi-asserted-by":"publisher","unstructured":"Vanherle, S., Loix, M., Miron, V. E., Hendriks, J. J. A., & Bogie, J. F. J. (2025). Lipid metabolism, remodelling and intercellular transfer in the CNS. Nature reviews. Neuroscience, 26(4), 214\u2013231. https:\/\/doi.org\/10.1038\/s41583-025-00908-3","DOI":"10.1038\/s41583-025-00908-3"},{"issue":"1","key":"2445_CR112","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1186\/s12885-023-11271-w","volume":"23","author":"N Sousa","year":"2023","unstructured":"Sousa N et al (2023) Targeting sphingolipid metabolism with the sphingosine kinase inhibitor SKI-II overcomes hypoxia-induced chemotherapy resistance in glioblastoma cells: effects on cell death, self-renewal, and invasion. BMC Cancer 23(1):762","journal-title":"BMC Cancer"},{"key":"2445_CR113","unstructured":"Marzoog BA, Vlasova TI (2021) Membrane lipids under norm and pathology"},{"issue":"1","key":"2445_CR114","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s40035-024-00433-w","volume":"13","author":"H Huang","year":"2024","unstructured":"Huang H, Xiang R, Yan R (2024) Linking APOE4\/4 genotype to microglial lipid droplets and neurotoxicity in alzheimer\u2019s disease. Transl Neurodegener 13(1):38","journal-title":"Transl Neurodegener"},{"key":"2445_CR115","unstructured":"Natalizi F (2025) Machine learning algorithm in predicting Alzheimer\u2019s disease: exploring brain volumetric markers and cognitive profiles in amnestic mild cognitive impairment patients"},{"key":"2445_CR116","doi-asserted-by":"crossref","unstructured":"Thiriet M (2019) Behavioral risk factors, in Vasculopathies: Behavioral, Chemical, Environmental, and genetic factors. Springer, pp 549\u2013594","DOI":"10.1007\/978-3-319-89315-0_6"},{"issue":"3","key":"2445_CR117","doi-asserted-by":"publisher","first-page":"e1002270","DOI":"10.1371\/journal.pmed.1002270","volume":"14","author":"H-M Lanoisel\u00e9e","year":"2017","unstructured":"Lanoisel\u00e9e H-M et al (2017) APP, PSEN1, and PSEN2 mutations in early-onset alzheimer disease: a genetic screening study of familial and sporadic cases. PLoS Med 14(3):e1002270","journal-title":"PLoS Med"},{"key":"2445_CR118","doi-asserted-by":"crossref","unstructured":"Reitz C, Rogaeva E, Beecham GW (2020) Late-onset vs nonmendelian early-onset alzheimer disease: a distinction without a difference?, vol 6. Genetics, Neurology, p e512","DOI":"10.1212\/NXG.0000000000000512"},{"issue":"24","key":"2445_CR119","doi-asserted-by":"publisher","first-page":"2788","DOI":"10.2174\/0929867321666140303142902","volume":"21","author":"M Segatto","year":"2014","unstructured":"Segatto M et al (2014) Cholesterol homeostasis failure in the brain: implications for synaptic dysfunction and cognitive decline. Curr Med Chem 21(24):2788\u20132802","journal-title":"Curr Med Chem"},{"issue":"8","key":"2445_CR120","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/S1474-4422(16)00127-7","volume":"15","author":"E Cuyvers","year":"2016","unstructured":"Cuyvers E, Sleegers K (2016) Genetic variations underlying alzheimer\u2019s disease: evidence from genome-wide association studies and beyond. Lancet Neurol 15(8):857\u2013868","journal-title":"Lancet Neurol"},{"issue":"5","key":"2445_CR121","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1111\/j.1474-9726.2012.00871.x","volume":"11","author":"WR Jeck","year":"2012","unstructured":"Jeck WR, Siebold AP, Sharpless NE (2012) A meta-analysis of GWAS and age\u2010associated diseases. Aging Cell 11(5):727\u2013731","journal-title":"Aging Cell"},{"issue":"6","key":"2445_CR122","doi-asserted-by":"publisher","first-page":"504","DOI":"10.3390\/cells13060504","volume":"13","author":"P Brlek","year":"2024","unstructured":"Brlek P et al (2024) Implementing whole genome sequencing (WGS) in clinical practice: advantages, challenges, and future perspectives. Cells 13(6):504","journal-title":"Cells"},{"key":"2445_CR123","unstructured":"Rojas Salarich Id (2023) Genetic and molecular biomarkers of Alzheimer\u2019s disease"},{"issue":"1","key":"2445_CR124","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12964-023-01072-w","volume":"21","author":"MR Khezri","year":"2023","unstructured":"Khezri MR, Mohebalizadeh M, Ghasemnejad-Berenji M (2023) Therapeutic potential of ADAM10 modulation in alzheimer\u2019s disease: a review of the current evidence. Cell Communication Signal 21(1):60","journal-title":"Cell Communication Signal"},{"key":"2445_CR125","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104511","author":"SJ Andrews","year":"2023","unstructured":"Andrews, S. J., Renton, A. E., Fulton-Howard, B., Podlesny-Drabiniok, A., Marcora, E., & Goate, A. M. (2023). The complex genetic architecture of Alzheimer's disease: novel insights and future directions. EBioMedicine, 90, 104511. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104511 https:\/\/doi.org\/10.1016\/j.ebiom.2023.104511","journal-title":"EBioMedicine"},{"issue":"11","key":"2445_CR126","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/s41582-022-00714-w","volume":"18","author":"L Migliore","year":"2022","unstructured":"Migliore L, Copped\u00e8 F (2022) Gene\u2013environment interactions in alzheimer disease: the emerging role of epigenetics. Nat Rev Neurol 18(11):643\u2013660","journal-title":"Nat Rev Neurol"},{"issue":"7","key":"2445_CR127","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/nan.12650","volume":"46","author":"AR Smith","year":"2020","unstructured":"Smith AR, Wheildon G, Lunnon K (2020) Invited review\u2013a 5-year update on epigenome\u2010wide association studies of DNA modifications in alzheimer\u2019s disease: progress, practicalities and promise. Neuropathol Appl Neurobiol 46(7):641\u2013653","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"5","key":"2445_CR128","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41580-021-00441-y","volume":"23","author":"M Shvedunova","year":"2022","unstructured":"Shvedunova M, Akhtar A (2022) Modulation of cellular processes by histone and non-histone protein acetylation. Nat Rev Mol Cell Biol 23(5):329\u2013349","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2445_CR129","unstructured":"Barciszewski J. Decoding Aging and Neuro-degeneration"},{"issue":"2","key":"2445_CR130","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3390\/jpm12020199","volume":"12","author":"G Mubarak","year":"2022","unstructured":"Mubarak G, Zahir FR (2022) Recent major transcriptomics and epitranscriptomics contributions toward personalized and precision medicine. J Personalized Med 12(2):199","journal-title":"J Personalized Med"},{"key":"2445_CR131","unstructured":"Kopkov\u00e1 A. Small non-coding RNAs as diagnostic biomarkers in brain tumors"},{"issue":"9","key":"2445_CR132","doi-asserted-by":"publisher","first-page":"6156","DOI":"10.1007\/s12035-019-1500-y","volume":"56","author":"S Swarbrick","year":"2019","unstructured":"Swarbrick S et al (2019) Systematic review of MiRNA as biomarkers in alzheimer\u2019s disease. Mol Neurobiol 56(9):6156\u20136167","journal-title":"Mol Neurobiol"},{"issue":"1","key":"2445_CR133","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/ncrna7010008","volume":"7","author":"C Kanach","year":"2021","unstructured":"Kanach C et al (2021) MicroRNAs as candidate biomarkers for alzheimer\u2019s disease. Non-coding RNA 7(1):8","journal-title":"Non-coding RNA"},{"issue":"12","key":"2445_CR134","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.3390\/cells13121063","volume":"13","author":"MS Ilieva","year":"2024","unstructured":"Ilieva MS (2024) Non-coding RNAs in neurological and neuropsychiatric disorders: unraveling the hidden players in disease pathogenesis. Cells 13(12):1063","journal-title":"Cells"},{"key":"2445_CR135","unstructured":"Kumar A et al (2018) Implication of preclinical biomarkers in"},{"issue":"4","key":"2445_CR136","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3390\/brainsci10040232","volume":"10","author":"L-N Schaffert","year":"2020","unstructured":"Schaffert L-N, Carter WG (2020) Do post-translational modifications influence protein aggregation in neurodegenerative diseases: a systematic review. Brain Sci 10(4):232","journal-title":"Brain Sci"},{"key":"2445_CR137","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3389\/fnagi.2019.00311","volume":"11","author":"A Chakravorty","year":"2019","unstructured":"Chakravorty A, Jetto CT, Manjithaya R (2019) Dysfunctional mitochondria and mitophagy as drivers of Alzheimer\u2019s disease pathogenesis. Front Aging Neurosci 11:311","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"2445_CR138","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1039\/D0MO00176G","volume":"17","author":"BC Muthubharathi","year":"2021","unstructured":"Muthubharathi BC, Gowripriya T, Balamurugan K (2021) Metabolomics: small molecules that matter more. Mol Omics 17(2):210\u2013229","journal-title":"Mol Omics"},{"key":"2445_CR139","doi-asserted-by":"publisher","first-page":"719","DOI":"10.3389\/fneur.2017.00719","volume":"8","author":"JM Wilkins","year":"2018","unstructured":"Wilkins JM, Trushina E (2018) Application of metabolomics in Alzheimer\u2019s disease. Front Neurol 8:719","journal-title":"Front Neurol"},{"issue":"5","key":"2445_CR140","doi-asserted-by":"publisher","first-page":"e63644","DOI":"10.1371\/journal.pone.0063644","volume":"8","author":"E Trushina","year":"2013","unstructured":"Trushina E et al (2013) Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and alzheimer\u2019s disease using metabolomics. PLoS ONE 8(5):e63644","journal-title":"PLoS ONE"},{"key":"2445_CR141","doi-asserted-by":"publisher","first-page":"101322","DOI":"10.1016\/j.redox.2019.101322","volume":"28","author":"W Shen","year":"2020","unstructured":"Shen W et al (2020) Homocysteine-methionine cycle is a metabolic sensor system controlling methylation-regulated pathological signaling. Redox Biol 28:101322","journal-title":"Redox Biol"},{"issue":"1","key":"2445_CR142","doi-asserted-by":"publisher","first-page":"6797","DOI":"10.1038\/s41598-024-56837-1","volume":"14","author":"T Oka","year":"2024","unstructured":"Oka T et al (2024) Multiomics analysis to explore blood metabolite biomarkers in an Alzheimer\u2019s disease neuroimaging initiative cohort. Sci Rep 14(1):6797","journal-title":"Sci Rep"},{"key":"2445_CR143","unstructured":"Awasthi A. Understanding genomic, transcriptomic, proteomic, and metabolomics approaches. Molecular Plant Pathol 38"},{"issue":"16","key":"2445_CR144","doi-asserted-by":"publisher","first-page":"4661","DOI":"10.3390\/jcm13164661","volume":"13","author":"A Bougea","year":"2024","unstructured":"Bougea A, Gourzis P (2024) Biomarker-Based precision therapy for alzheimer\u2019s disease: multidimensional evidence leading a new breakthrough in personalized medicine. J Clin Med 13(16):4661","journal-title":"J Clin Med"},{"issue":"1","key":"2445_CR145","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13024-024-00711-1","volume":"19","author":"X Zeng","year":"2024","unstructured":"Zeng X et al (2024) Alzheimer blood biomarkers: practical guidelines for study design, sample collection, processing, biobanking, measurement and result reporting. Mol Neurodegener 19(1):40","journal-title":"Mol Neurodegener"},{"issue":"4","key":"2445_CR146","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1021\/acsbiomedchemau.5c00074","volume":"5","author":"HA Adeola","year":"2025","unstructured":"Adeola HA, Robinson RA (2025) Bridging health disparity gaps in Alzheimer\u2019s disease among marginalized populations: clinical proteomics as a case study. ACS Bio Med Chem Au 5(4):505\u2013518","journal-title":"ACS Bio Med Chem Au"},{"issue":"6","key":"2445_CR147","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1007\/s10072-025-08023-y","volume":"46","author":"V Bhatia","year":"2025","unstructured":"Bhatia V et al (2025) Advances in biomarker discovery and diagnostics for alzheimer\u2019s disease. Neurol Sci 46(6):2419\u20132436","journal-title":"Neurol Sci"},{"key":"2445_CR148","doi-asserted-by":"crossref","unstructured":"Sah AK (2025) Prognostic biomarkers: predicting disease outcomes.\u00a0The potential of cancer biomarkers. Elsevier, pp 211\u2013238","DOI":"10.1016\/B978-0-443-29279-8.00010-7"},{"key":"2445_CR149","doi-asserted-by":"publisher","unstructured":"Murray, M. E., Smith, C., Menon, V., Keene, C. D., Lein, E., Hawrylycz, M., Aguzzi, A., Benedetti, B., Brose, K., Caetano-Anolles, K., Sillero, M. I. C., Crary, J. F., De Jager, P. L., Faustin, A., Flanagan, M. E., Gokce, O., Grant, S. G. N., Grinberg, L. T., Gutman, D. A., Hillman, E. M. C., \u2026 Phatnani, H. (2025). Accelerating biomedical discoveries in brain health through transformative neuropathology of aging and neurodegeneration. Neuron, 113(22), 3703\u20133721. https:\/\/doi.org\/10.1016\/j.neuron.2025.06.014","DOI":"10.1016\/j.neuron.2025.06.014"},{"issue":"1","key":"2445_CR150","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1186\/s40001-024-01915-3","volume":"29","author":"I Iqbal","year":"2024","unstructured":"Iqbal I et al (2024) Alzheimer\u2019s disease and drug delivery across the blood\u2013brain barrier: approaches and challenges. Eur J Med Res 29(1):313","journal-title":"Eur J Med Res"},{"issue":"7","key":"2445_CR151","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.3390\/pharmaceutics13071084","volume":"13","author":"K-T Chen","year":"2021","unstructured":"Chen K-T, Wei K-C, Liu H-L (2021) Focused ultrasound combined with microbubbles in central nervous system applications. Pharmaceutics 13(7):1084","journal-title":"Pharmaceutics"},{"issue":"1","key":"2445_CR152","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","volume":"8","author":"D Wu","year":"2023","unstructured":"Wu D et al (2023) The blood\u2013brain barrier: Structure, regulation and drug delivery. Signal Transduct Target Therapy 8(1):217","journal-title":"Signal Transduct Target Therapy"},{"key":"2445_CR153","unstructured":"Mess GA (2022) Focused ultrasound for the treatment of glioblastoma multiforme: from computer modelling to blood brain barrier openings. Johns Hopkins University"},{"issue":"4","key":"2445_CR154","doi-asserted-by":"publisher","first-page":"975","DOI":"10.14283\/jpad.2024.85","volume":"11","author":"A Patwardhan","year":"2024","unstructured":"Patwardhan A et al (2024) Safety, efficacy and clinical applications of focused Ultrasound-Mediated blood brain barrier opening in alzheimer\u2019s disease: A systematic review. J Prev Alzheimer\u2019s Disease 11(4):975\u2013982","journal-title":"J Prev Alzheimer\u2019s Disease"},{"key":"2445_CR155","doi-asserted-by":"publisher","first-page":"880814","DOI":"10.3389\/fneur.2022.880814","volume":"13","author":"H Baek","year":"2022","unstructured":"Baek H et al (2022) Clinical intervention using focused ultrasound (FUS) stimulation of the brain in diverse neurological disorders. Front Neurol 13:880814","journal-title":"Front Neurol"},{"issue":"5","key":"2445_CR156","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1208\/s12249-024-02810-0","volume":"25","author":"A Ghosh","year":"2024","unstructured":"Ghosh A et al (2024) In-depth mechanism, challenges, and opportunities of delivering therapeutics in brain using intranasal route. AAPS PharmSciTech 25(5):96","journal-title":"AAPS PharmSciTech"},{"issue":"2","key":"2445_CR157","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1080\/09205063.2024.2396721","volume":"36","author":"A Kumar","year":"2025","unstructured":"Kumar A, Shukla R (2025) Current strategic arsenal and advances in nose to brain nanotheranostics for therapeutic intervention of glioblastoma multiforme. J Biomater Sci Polym Ed 36(2):212\u2013246","journal-title":"J Biomater Sci Polym Ed"},{"key":"2445_CR158","doi-asserted-by":"publisher","first-page":"889","DOI":"10.35812\/CelluloseChemTechnol.2020.54.86","volume":"54","author":"IM Pelin","year":"2020","unstructured":"Pelin IM, Suflet DM (2020) Mucoadhesive buccal drug delivery systems containing polysaccharides. Cellul Chem Technol 54:889\u2013902","journal-title":"Cellul Chem Technol"},{"issue":"2","key":"2445_CR159","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3390\/pharmaceutics17020148","volume":"17","author":"I B\u00e1cskay","year":"2025","unstructured":"B\u00e1cskay I et al (2025) Bioavailability enhancement and formulation technologies of oral mucosal dosage forms: a review. Pharmaceutics 17(2):148","journal-title":"Pharmaceutics"},{"issue":"12","key":"2445_CR160","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.3390\/pharmaceutics16121563","volume":"16","author":"R Sabra","year":"2024","unstructured":"Sabra R et al (2024) Buccal absorption of biopharmaceutics classification system Iii drugs: formulation approaches and mechanistic insights. Pharmaceutics 16(12):1563","journal-title":"Pharmaceutics"},{"key":"2445_CR161","doi-asserted-by":"crossref","unstructured":"Sandri G et al (2015) Mucoadhesive polymers as enabling excipients for oral mucosal drug delivery. Oral mucosal drug delivery and therapy. Springer 53\u201388","DOI":"10.1007\/978-1-4899-7558-4_4"},{"issue":"22","key":"2445_CR162","doi-asserted-by":"publisher","first-page":"e3026","DOI":"10.1212\/WNL.0000000000010814","volume":"95","author":"J Hanes","year":"2020","unstructured":"Hanes J et al (2020) Evaluation of a novel immunoassay to detect p-tau Thr217 in the CSF to distinguish alzheimer disease from other dementias. Neurology 95(22):e3026\u2013e3035","journal-title":"Neurology"}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-025-02445-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12031-025-02445-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-025-02445-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T03:02:28Z","timestamp":1774407748000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12031-025-02445-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":162,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["2445"],"URL":"https:\/\/doi.org\/10.1007\/s12031-025-02445-1","relation":{},"ISSN":["1559-1166"],"issn-type":[{"value":"1559-1166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,22]]},"assertion":[{"value":"26 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"3"}}